Trial results
$FDMT — 4D-150
4D Molecular Therapeutics, Inc. (FDMT) 4D-150: trial results in wet AMD, 2027.
The catalyst
"We anticipate topline data for 4FRONT-1 in the second quarter of 2027."
— 4D Molecular Therapeutics, 10-Q filed 2026-11-12 · the filing. Checked word for word against the stored document when this page was built; a sentence that did not check out would not be here.
- Event id
FDMT-4D150-2026- Company
- 4D Molecular Therapeutics, Inc.
- Kind
- Trial results
- Indication
- wet AMD
- Window
- 2027-01-01 – 2027-12-31
- Status
- dropped
The bar
No bar has been published for this event yet.
Verdicts
No verdict has been published for this event yet.